{{Drugbox | Verifiedfields = | Watchedfields = | verifiedrevid = | IUPAC_name = 4-({2-[(1R,2R,3aS,3bS,10aR,10bS,11S,12aS)-1,11-Dihydroxy-2,5,10a,12a-tetramethyl-7-phenyl-1,2,3,3a,3b,7,10,10a,10b,11,12,12a-dodecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-yl]-2-oxoethoxy}carbonyl)benzenesulfonic acid | image = Cortisuzol.svg | width = | tradename = Solu-Altim | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = | CAS_number = 50801-44-0 | CAS_supplemental = | class = Corticosteroid; Glucocorticoid | ATC_prefix = | ATC_suffix = | ATC_supplemental = | PubChem = 3037936 | IUPHAR_ligand = | DrugBank_Ref = | DrugBank = | ChemSpiderID_Ref = | ChemSpiderID = 16736901 | UNII = 1PA76KJ99Y | KEGG = | ChEBI = | ChEMBL = 2106054 | C=37 | H=40 | N=2 | O=8 | S=1 | SMILES = C[C@@H]1C[C@H]2[C@@H]3C=C(C4=CC5=C(C[C@@]4([C@H]3[C@H](C[C@@]2([C@]1(C(=O)COC(=O)C6=CC(=CC=C6)S(=O)(=O)O)O)C)O)C)C=NN5C7=CC=CC=C7)C | StdInChI_Ref = | StdInChI = 1S/C37H40N2O8S/c1-21-13-27-29-14-22(2)37(43,32(41)20-47-34(42)23-9-8-12-26(15-23)48(44,45)46)36(29,4)18-31(40)33(27)35(3)17-24-19-38-39(30(24)16-28(21)35)25-10-6-5-7-11-25/h5-13,15-16,19,22,27,29,31,33,40,43H,14,17-18,20H2,1-4H3,(H,44,45,46)/t22-,27+,29+,31+,33-,35+,36+,37+/m1/s1 | StdInChIKey_Ref = | StdInChIKey = ZKIDWWQMNXGYHV-BYJSBFAFSA-N | synonyms = RU-16999; 11β,17α,21-Trihydroxy-6,16α-dimethyl-2'-phenyl-2H-pregna-2,4,6-trieno[3,2-c]pyrazol-20-one 21-(m''-sulfobenzoate) }}Cortisuzol (brand name Solu-Altim; developmental code name RU-16999''') is a synthetic glucocorticoid corticosteroid. References Benzoate esters Ketones Glucocorticoids Sulfonic acids Phenyl compounds Pregnanes Pyrazoles Triols